Circulating growth factors data associated with insulin secretagogue use in women with incident breast cancer
Oral drugs stimulating insulin production may impact growth factor levels. The data presented shows the relationship between pre-existing insulin secretagogues use, growth factor profiles at the time of breast cancer diagnosis and subsequent cancer outcomes in women diagnosed with breast cancer and...
Main Authors: | Zachary A.P. Wintrob, Jeffrey P. Hammel, George K. Nimako, Dan P. Gaile, Alan Forrest, Alice C. Ceacareanu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-04-01
|
Series: | Data in Brief |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352340917300574 |
Similar Items
-
Dataset on growth factor levels and insulin use in patients with diabetes mellitus and incident breast cancer
by: Zachary A.P. Wintrob, et al.
Published: (2017-04-01) -
Circulating adipokines data associated with insulin secretagogue use in breast cancer patients
by: Zachary A.P. Wintrob, et al.
Published: (2017-02-01) -
Dataset on granulopoiesis- and lymphopoiesis-stimulating cytokine levels in insulin secretagogue users with incident breast cancer
by: Zachary A.P. Wintrob, et al.
Published: (2017-04-01) -
Insulin secretagogue use and circulating inflammatory C–C chemokine levels in breast cancer patients
by: Zachary A.P. Wintrob, et al.
Published: (2017-04-01) -
TH1 and TH2 cytokine data in insulin secretagogues users newly diagnosed with breast cancer
by: Zachary A.P. Wintrob, et al.
Published: (2017-04-01)